C9163 – Injection, talquetamab-tgvs, 0.25 mg
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9163
- Long description
- Injection, talquetamab-tgvs, 0.25 mg
- Short description
- Inj talquetamab-tgvs 0.25 mg
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- Added
- January 1, 2024
- Last change
- April 1, 2024 – No change
- Termination date
- March 31, 2024
Frequently asked questions
What is HCPCS code C9163?
C9163 is a HCPCS Level II code for injection, talquetamab-tgvs, 0.25 mg. It was discontinued on March 31, 2024.
Does Medicare cover C9163?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9155 – Injection, epcoritamab-bysp, 0.16 mg
- C9156 – Flotufolastat f 18, diagnostic, 1 millicurie
- C9157 – Injection, tofersen, 1 mg
- C9158 – Injection, risperidone, (uzedy), 1 mg
- C9159 – Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity
- C9160 – Injection, daxibotulinumtoxina-lanm, 1 unit
- C9161 – Injection, aflibercept hd, 1 mg
- C9162 – Injection, avacincaptad pegol, 0.1 mg
- C9164 – Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
- C9165 – Injection, elranatamab-bcmm, 1 mg
- C9166 – Injection, secukinumab, intravenous, 1 mg
- C9167 – Injection, adamts13, recombinant-krhn, 10 iu
- C9168 – Injection, mirikizumab-mrkz, 1 mg
- C9169 – Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram
- C9170 – Injection, tarlatamab-dlle, 1 mg
- C9171 – Injection, pegulicianine, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.